Zhangzhou Pientzehuang Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Zhangzhou Pientzehuang Pharmaceutical has a total shareholder equity of CN¥14.6B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 7.3%. Its total assets and total liabilities are CN¥18.0B and CN¥3.4B respectively. Zhangzhou Pientzehuang Pharmaceutical's EBIT is CN¥3.5B making its interest coverage ratio -27.1. It has cash and short-term investments of CN¥3.3B.
Key information
7.3%
Debt to equity ratio
CN¥1.06b
Debt
| Interest coverage ratio | -27.1x |
| Cash | CN¥3.27b |
| Equity | CN¥14.60b |
| Total liabilities | CN¥3.39b |
| Total assets | CN¥17.99b |
Recent financial health updates
Recent updates
Earnings Beat: Zhangzhou Pientzehuang Pharmaceutical., Ltd Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Oct 22
Estimating The Intrinsic Value Of Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436)
Sep 08Earnings Miss: Zhangzhou Pientzehuang Pharmaceutical., Ltd Missed EPS By 39% And Analysts Are Revising Their Forecasts
Aug 20Subdued Growth No Barrier To Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Price
Jul 12These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely
May 27Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Business Is Yet to Catch Up With Its Share Price
Feb 28Financial Position Analysis
Short Term Liabilities: 600436's short term assets (CN¥15.8B) exceed its short term liabilities (CN¥3.1B).
Long Term Liabilities: 600436's short term assets (CN¥15.8B) exceed its long term liabilities (CN¥289.5M).
Debt to Equity History and Analysis
Debt Level: 600436 has more cash than its total debt.
Reducing Debt: 600436's debt to equity ratio has reduced from 12% to 7.3% over the past 5 years.
Debt Coverage: 600436's debt is well covered by operating cash flow (106%).
Interest Coverage: 600436 earns more interest than it pays, so coverage of interest payments is not a concern.